Riaz Qureshi, PhD, MS

Assistant Professor, Ophthalmology

FacultyPhoto

Website

Graduate Schools
  • PhD, Johns Hopkins University Bloomberg School of Public Health (2021)
  • MSc, University of Western Ontario (2017)
Undergraduate School
  • BSc (Hons), University of Waterloo (2015)
Languages
English
Department
Ophthalmology

Professional Titles

  • Assistant Professor

Recognitions

  • David Sackett Young Investigator Award, Journal of Clinical Epidemiology (2023)
    Paper of the Year award - The award recognizes outstanding papers by young researchers that exemplify the values of creativity and scientific excellence. To be eligible for the David Sackett Young Investigator Award 2023, the young investigator had to be the first author of the nominated article, and younger than 35 at the time of submission.

Research Interests

Methodologically, my research focuses on evidence synthesis (e.g., systematic review and meta-analysis) and clinical trials methods and meta-research in general. My unit of analysis for my work is almost always "studies" as I try to assess how we can do research better. I am particularly interested in the methods used to investigate harms of interventions at different levels of evidence: from adverse events collected and reported in clinical trials to the synthesis of harms in systematic reviews.

Publications

  • Qureshi R, Mayo-Wilson E, Li T. Harms in Systematic Reviews Paper 1: An introduction to research on harms. J Clin Epidemiol. 2022 Mar;143:186-196. PubMed PMID: 34742788
  • Qureshi R, Mayo-Wilson E, Rittiphairoj T, McAdams-DeMarco M, Guallar E, Li T. Harms in Systematic Reviews Paper 2: Methods used to assess harms are neglected in systematic reviews of gabapentin. J Clin Epidemiol. 2022 Mar;143:212-223. PubMed PMID: 34742789
  • Qureshi R, Mayo-Wilson E, Rittiphairoj T, McAdams-DeMarco M, Guallar E, Li T. Harms in Systematic Reviews Paper 3: Given the same data sources, systematic reviews of gabapentin have different results for harms. J Clin Epidemiol. 2022 Mar;143:224-241. PubMed PMID: 34742790
  • Phillips R, Cro S, Wheeler G, Bond S, Morris TP, Creanor S, Hewitt C, Love S, Lopes A, Schlackow I, Gamble C, MacLennan G, Habron C, Gordon AC, Vergis N, Li T, Qureshi R, Everett CC, Holmes J, Kirkham A, Peckitt C, Pirrie S, Ahmed N, Collett L, Cornelius V. Visualising harms in publications of randomised controlled trials: consensus and recommendations. BMJ. 2022 May 16;377:e068983. PubMed PMID: 35577357
  • Qureshi R, Gough A, Loudon K. The SPIRIT Checklist-lessons from the experience of SPIRIT protocol editors. Trials. 2022 Apr 27;23(1):359. PubMed PMID: 35477436
  • Protasio JN, King A, Pasquale LR, Barton K, Bonnar J, Qureshi R, Virgili G, Azuara-Blanco A. How Can We Quantify and Compare Harm in Surgical Trials?. Am J Ophthalmol. 2022 Sep;241:64-70. PubMed PMID: 35526589
  • McCann P, Kruoch Z, Qureshi R, Li T. Effectiveness of interventions for dry eye: a protocol for an overview of systematic reviews. BMJ Open. 2022 Jun 7;12(6):e058708. PubMed PMID: 35672062
  • Qureshi R, Chen X, Goerg C, Mayo-Wilson E, Dickinson S, Golzarri-Arroyo L, Hong H, Phillips R, Cornelius V, McAdams DeMarco M, Guallar E, Li T. Comparing the Value of Data Visualization Methods for Communicating Harms in Clinical Trials. Epidemiol Rev. 2022 Dec 21;44(1):55-66. PubMed PMID: 36065832
  • Lee MJ, Lin JC, Qureshi R, Greenberg PB. Predictors of citation count for systematic reviews in ophthalmology. Graefes Arch Clin Exp Ophthalmol. 2023 Jan;261(1):281-282. PubMed PMID: 35943581
  • McCann P, Abraham AG, Mukhopadhyay A, Panagiotopoulou K, Chen H, Rittiphairoj T, Gregory DG, Hauswirth SG, Ifantides C, Qureshi R, Liu SH, Saldanha IJ, Li T. Prevalence and Incidence of Dry Eye and Meibomian Gland Dysfunction in the United States: A Systematic Review and Meta-analysis. JAMA Ophthalmol. 2022 Dec 1;140(12):1181-1192. PubMed PMID: 36301551
  • Kang C, Lin JC, Qureshi R, Scherer R, Greenberg PB. Author, study, and publication metrics of brief reports and full-length research articles in ophthalmology journals. Clin Exp Ophthalmol. 2022 Dec 23. [Epub ahead of print] PubMed PMID: 36562707
  • Monaco W, Qureshi R, Meng H, Arif A, Aggarwal S. Risk factors for vision loss among nursing home residents: A cross-sectional analysis. Investigative Ophthalmology and Visual Science. 2022; 63(7):4238
  • Qureshi R, E JY, Han G, Rittiphairoj T, Ng S, Wilson R, Abariga S, Li T. Certainty of evidence in Cochrane Eyes and Vision systematic reviews. Investigative Ophthalmology and Visual Science. 2022; 63(7):2137
  • Qureshi R, Phillips R, Cornelius V, Mayo-Wilson E, Goerg C, Li T. Data visualization approaches to presenting harms in clinical trials. Clinical Trials. 2022; 64-65 [CP I 5-4]
  • Zhu AS, Lin JC, Kang C, Qureshi R, Scherer RW, Greenberg PB. Predictors of Citations for Original Research in Ophthalmology. Semin Ophthalmol. 2023 May;38(4):398-401. PubMed PMID: 36697379
  • Monaco W, Qureshi R, Arif A, Aggarwal S, Meng H. Risk Factors for Vision Loss among Nursing Home Residents: A Cross-Sectional Analysis. J Am Med Dir Assoc. 2023 Jan;24(1):105-112.e1. PubMed PMID: 36442539
  • Lê JT, Qureshi R, Rouse B, Twose C, Rosman L, Lindsley K, Hawkins BS, Li T. Development and content of a database of systematic reviews for eyes and vision. Eye (Lond). 2022 Apr;36(4):883-885. PubMed PMID: 33824507
  • Qureshi R, Azuara-Blanco A, Michelessi M, Virgili G, Barbosa Breda J, Cutolo CA, Pazos M, Katsanos A, Garhöfer G, Kolko M, Prokosch-Willing V, Al Rajhi AA, Lum F, Musch D, Gedde S, Li T. What Do We Really Know about the Effectiveness of Glaucoma Interventions?: An Overview of Systematic Reviews. Ophthalmol Glaucoma. 2021 Sep-Oct;4(5):454-462. PubMed PMID: 33571689
  • Jia Y, Huang D, Wen J, Liang J, Qureshi R, Wang Y, Rosman L, Chen Q, Robinson KA, Gagnier JJ, Celentano DD, Ehrhardt S. Association between switching of primary outcomes and reported trial findings among randomized drug trials from China. J Clin Epidemiol. 2021 Apr;132:10-17. PubMed PMID: 33309887
  • Michelessi M, Li T, Miele A, Azuara-Blanco A, Qureshi R, Virgili G. Accuracy of optical coherence tomography for diagnosing glaucoma: an overview of systematic reviews. Br J Ophthalmol. 2021 Apr;105(4):490-495. PubMed PMID: 32493760
  • Qureshi R, Lê J, Li T, Ibrahim M, Dickersin K. Gender and Editorial Authorship in High-Impact Epidemiology Journals. Am J Epidemiol. 2019 Dec 31;188(12):2140-2145. PubMed PMID: 30995311
  • Le JT, Qureshi R, Twose C, Rosman L, Han G, Fapohunda K, Saldanha IJ, Scherer RW, Lum F, Al-Rajhi A, Musch DC, Hawkins BS, Dickersin K, Li T. Evaluation of Systematic Reviews of Interventions for Retina and Vitreous Conditions. JAMA Ophthalmol. 2019 Dec 1;137(12):1399-1405. PubMed PMID: 31600387
  • Le JT, Qureshi R, Li T. Reply. Ophthalmology. 2019 Apr;126(4):e28-e29. PubMed PMID: 30910045
  • Dickersin K, Qureshi R. The Importance of Reporting Biases in Patient Care: Can We Trust the Evidence From Either Individual Studies or Systematic Reviews?. Ann Intern Med. 2018 Sep 18;169(6):413-414. PubMed PMID: 30140919
  • Le JT, Qureshi R, Li T. Open Access Journals in Ophthalmology and Vision Science: All That Glitters Is Not Gold. Ophthalmology. 2018 Sep;125(9):1314-1316. PubMed PMID: 30143087
  • Sutton D, Qureshi R, Martin J. Evidence reversal-when new evidence contradicts current claims: a systematic overview review of definitions and terms. J Clin Epidemiol. 2018 Feb;94:76-84. PubMed PMID: 29045807
  • McCann P, Kruoch Z, Lopez S, Malli S, Qureshi R, Li T. Interventions for Dry Eye: An Overview of Systematic Reviews. JAMA Ophthalmol. 2023 Dec 21. [Epub ahead of print] PubMed PMID: 38127364
  • Mayo-Wilson E, Chen X, Qureshi R, Dickinson S, Golzarri-Arroyo L, Hong H, Görg C, Li T. Restoring invisible and abandoned trials of gabapentin for neuropathic pain: a clinical and methodological investigation. BMJ Open. 2021 Jun 30;11(6):e047785. PubMed PMID: 34193496
  • Li T, McCann PM, Wilting S, McNamara S, Gregory DG, Hauswirth SG, Ifantides C, Benning L, Sequeira TA, Qureshi R, Liu SH, Clark MA, Saldanha IJ, Abraham AG. Prolonged facemask wearing among hospital workers and dry eye - a mixed-methods study. BMC Ophthalmol. 2023 Oct 19;23(1):420. PubMed PMID: 37858059
  • Ong ZZ, Sadek Y, Liu X, Qureshi R, Liu SH, Li T, Sounderajah V, Ashrafian H, Ting DSW, Said DG, Mehta JS, Burton MJ, Dua HS, Ting DSJ. Diagnostic performance of deep learning in infectious keratitis: a systematic review and meta-analysis protocol. BMJ Open. 2023 May 10;13(5):e065537. PubMed PMID: 37164459
  • Qureshi R, Shaughnessy D, Gill KAR, Robinson KA, Li T, Agai E. Are ChatGPT and large language models "the answer" to bringing us closer to systematic review automation?. Syst Rev. 2023 Apr 29;12(1):72. PubMed PMID: 37120563
  • Stapleton F, Abad JC, Barabino S, Burnett A, Iyer G, Lekhanont K, Li T, Liu Y, Navas A, Obinwanne CJ, Qureshi R, Roshandel D, Sahin A, Shih K, Tichenor A, Jones L. TFOS lifestyle: Impact of societal challenges on the ocular surface. Ocul Surf. 2023 Apr;28:165-199. PubMed PMID: 37062429
  • Downie LE, Britten-Jones AC, Hogg RE, Jalbert I, Li T, Lingham G, Liu SH, Qureshi R, Saldanha IJ, Singh S, Craig JP. TFOS Lifestyle - Evidence quality report: Advancing the evaluation and synthesis of research evidence. Ocul Surf. 2023 Apr;28:200-212. PubMed PMID: 37054912
  • Mayo-Wilson E, Qureshi R, Li T. Conducting separate reviews of benefits and harms could improve systematic reviews and meta-analyses. Syst Rev. 2023 Apr 15;12(1):67. PubMed PMID: 37061724
  • Zhu AS, Lin JC, Kang C, Qureshi R, Scherer RW, Greenberg PB. Predictors of Citations for Original Research in Ophthalmology. Semin Ophthalmol. 2023 May;38(4):398-401. PubMed PMID: 36697379
  • Monaco W, Qureshi R, Arif A, Aggarwal S, Meng H. Risk Factors for Vision Loss among Nursing Home Residents: A Cross-Sectional Analysis. J Am Med Dir Assoc. 2023 Jan;24(1):105-112.e1. PubMed PMID: 36442539
  • Lee MJ, Lin JC, Qureshi R, Greenberg PB. Predictors of citation count for systematic reviews in ophthalmology. Graefes Arch Clin Exp Ophthalmol. 2023 Jan;261(1):281-282. PubMed PMID: 35943581
  • Kruoch Z, Amin P, Shelton E, Zimmerman A, Stephey E, Hunter M, Downie L, Qureshi R. Behavioral interventions to improve treatment adherence of glaucoma (Protocol). Cochrane Database of Systematic Reviews, 2023; 5:CD015788. DOI: 10.1002/14651858.CD015788
  • Mallios J, Chen D, Wang J, Han S, Summers A, Rice M, Scheiman M, Harb E, Qureshi R. Interventions for improving adherence to amblyopia treatments in children (Protocol). Cochrane Database of Systematic Reviews, 2023; 8:CD015820. DOI: 10.1002/14651858.CD015820

Professional Memberships

  • Society for Research Synthesis Methods, Member
  • Cochrane, Faculty methodologist
Personal Interests
I have many hobbies that I enjoy in my spare time with friends and my wiife including: playing and enjoying live music, hiking, computer gaming, archery/target shooting, miniature painting, leatherworking, and cocktail making.

Public Speaking
Yes
I have been invited to speak about systematic review and clinical trial methods around the world, primarily around harms (i.e., adverse events) and artificial intelligence (e.g., large language models).


School of Medicine

CU Anschutz
Fitzsimons Building

13001 East 17th Place

Aurora, CO 80045

303.724.5375

School
General
Students